MTS Medication Technologies (MTSI) Reaffirms FY09 Outlook
MTS Medication Technologies, Inc. (Nasdaq: MTSI) expects to reaffirm its FY09 guidance for sales in the range of $75-$78 million and EPS in the range of $0.35-$0.40. The Street estimates are for sales of $76.20 million and EPS of $0.36. (only 1 analyst covers the stock)
MTS Medication Technologies, Inc., through its subsidiaries, manufactures and sells consumable medication punch cards, packaging equipment, and ancillary products in the United States, Canada, and Europe.
MTS Medication Technologies, Inc., through its subsidiaries, manufactures and sells consumable medication punch cards, packaging equipment, and ancillary products in the United States, Canada, and Europe.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- VeriFone Systems (PAY) Tops Q2 EPS by 3c; Guides Q3, FY12
- ATA, Inc. (ATAI) Misses Q4 EPS by 1c; Guides FY13 Revs Below
Create E-mail Alert Related Categories
GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
